Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease

Clinical and Experimental Rheumatology

Volumn 30, Issue 3, 2012, Pages 450-

  Tada, Y ^a   Suematsu, E ^b   Ueda, A ^c   Nagano, S ^d   Sawabe, T ^e   Nishizaka, H ^f   Horiuchi, T ^g  

^a SAGA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

^d OITA RED CROSS HOSPITAL   (Japan)

^e ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^f KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; JO 1 ANTIBODY; LACTATE DEHYDROGENASE; METHOTREXATE; TACROLIMUS;

ADULT; ARTERIAL OXYGEN TENSION; CLINICALLY AMYOPATHIC DERMATOMYOSITIS; DEATH; DERMATOMYOSITIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL LUNG DISEASE; LETTER; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY;

ANTIRHEUMATIC AGENTS; DERMATOMYOSITIS; DRUG RESISTANCE; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84864766512     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. KANG EH, LEE EB, SHIN KC et al.: Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology 2005; 44: 1282-6.
2. YE S, CHEN X, LU X et al.: Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol 2007; 26: 1647-54.
3. SONTHEIMER RD, MIYAGAWA S: Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis. J Am Acad Dermatol 2003; 48: 797-8.
4. NAWATA Y, KURASAWA K, TAKABAYASHI K et al.: Corticosteroid resistant interstitial pneumonitis in dermatomyositis/ polymyositis: prediction and treatment with cyclosporine. J Rheumatol 1999; 26: 1527-33.
5. KAMEDA H, NAGASAWA H, OGAWA H et al.: Combination therapy with corticosteroids, cyclosporine A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 2005; 32: 1719-26.
6. YAMASAKI Y, YAMADA H, YAMASAKI M et al.: Intravenous cyclophosphamide therapy for progressiveinterstitial pneumonia in patients with polymyositis/ dermatomyositis. Rheumatology 2007; 46: 124-30.
7. KOTANI T, MAKINO S, TAKEUCHI T et al.: Early intervention with corticosteroids and cyclosporine A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis. J Rheumatol 2008; 35: 254-9.
8. FENDLER C, BRAUN J: Use of methotrexate in inflammatory myopathies. Clin Exp Rheumatol 2010; 28 (Suppl. 61): S164-7.
9. BOHAN A, PETER JB: Polymyositis and dermatomyositis (first of 2 parts). N Engl J Med 1975; 292: 344-7.
10. GERAMI P, SCOPE JM, MCDONALD L, WALLING HW, SONTHEIMER RD: A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): A missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatology 2006; 54: 597-613.